A Central Amygdala-Ventrolateral Periaqueductal Gray Matter Pathway for Pain in a Mouse Model of Depression-like Behavior

被引:44
|
作者
Yin, Weiwei [1 ]
Mei, Lisheng [1 ]
Sun, Tingting [1 ]
Wang, Yuping [1 ]
Li, Jie [1 ]
Chen, Changmao [1 ]
Farzinpour, Zahra [1 ]
Mao, Yu [1 ,3 ]
Tao, Wenjuan [1 ,3 ]
Li, Juan [1 ]
Xie, Wen [2 ]
Zhang, Zhi [1 ,2 ]
机构
[1] Univ Sci & Technol China, Chinese Acad Sci, Dept Biophys & Neurobiol, Hefei Natl Lab Phys Sci Microscale,Key Lab Brain, Hefei, Peoples R China
[2] Anhui Mental Hlth Ctr, Dept Psychol, Hefei, Peoples R China
[3] Anhui Med Univ, Sch Basic Med Sci, Dept Physiol, Hefei, Peoples R China
基金
中国国家自然科学基金;
关键词
RESTRAINT STRESS; SEX-DIFFERENCES; FUNCTIONAL CONNECTIVITY; NEUROPATHIC PAIN; NMDA RECEPTOR; BRAIN; KETAMINE; MEMORY; CIRCUITS; ANTIDEPRESSANTS;
D O I
10.1097/ALN.0000000000003133
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: The mechanisms underlying depression-associated pain remain poorly understood. Using a mouse model of depression, the authors hypothesized that the central amygdala-periaqueductal gray circuitry is involved in pathologic nociception associated with depressive states. Methods: The authors used chronic restraint stress to create a mouse model of nociception with depressive-like behaviors. They then used retrograde tracing strategies to dissect the pathway from the central nucleus of the amygdala to the ventrolateral periaqueductal gray. The authors performed optogenetic and chemogenetic experiments to manipulate the activity of this pathway to explore its roles for nociception. Results: The authors found that gamma-aminobutyric acid-mediated (GABAergic) neurons from the central amygdala project onto GABAergic neurons of the ventrolateral periaqueductal gray, which, in turn, locally innervate their adjacent glutamatergic neurons. After chronic restraint stress, male mice displayed reliable nociception (control, mean +/- SD: 0.34 +/- 0.11 g, n = 7 mice; chronic restraint stress, 0.18 +/- 0.11 g, n = 9 mice, P = 0.011). Comparable nociception phenotypes were observed in female mice. After chronic restraint stress, increased circuit activity was generated by disinhibition of glutamatergic neurons of the ventrolateral periaqueductal gray by local GABAergic interneurons via receiving enhanced central amygdala GABAergic inputs. Inhibition of this circuit increased nociception in chronic restraint stress mice (median [25th, 75th percentiles]: 0.16 [0.16, 0.16] g to 0.07 [0.04, 0.16] g, n = 7 mice per group, P < 0.001). In contrast, activation of this pathway reduced nociception (mean +/- SD: 0.16 +/- 0.08 g to 0.34 +/- 0.13 g, n = 7 mice per group, P < 0.001). Conclusions: These findings indicate that the central amygdala-ventrolateral periaqueductal gray pathway may mediate some aspects of pain symptoms under depression conditions.
引用
收藏
页码:1175 / 1196
页数:22
相关论文
共 50 条
  • [21] Alleviation of depression-like behavior in a cystic fibrosis mouse model by Hdac6 depletion
    Corey, Deborah A.
    Rymut, Sharon M.
    Kelley, Thomas J.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [22] Histamine 3 receptor antagonism mitigates neuroinflammation and depression-like behavior in a mouse model of food allergy
    Germundson-Hermanson, Danielle La Mae
    Nagamoto-Combs, Kumi
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [23] Agmatine ameliorates manifestation of depression-like behavior and hippocampal neuroinflammation in mouse model of Alzheimer's disease
    Kotagale, Nandkishor
    Deshmukh, Rupali
    Dixit, Madhura
    Fating, Rajshree
    Umekar, Milind
    Taksande, Brijesh
    BRAIN RESEARCH BULLETIN, 2020, 160 : 56 - 64
  • [24] Ophiocordyceps formosana improves hyperglycemia and depression-like behavior in an STZ-induced diabetic mouse model
    Huang, Chao-Wei
    Hong, Tzu-Wen
    Wang, Ying-Jing
    Chen, Ko-Chien
    Pei, Ju-Chun
    Chuang, Tai-Yuan
    Lai, Wen-Sung
    Tsai, Sheng-Hong
    Chu, Richard
    Chen, Wei-Cheng
    Sheen, Lee-Yan
    Takahashi, Satoru
    Ding, Shih-Torng
    Shen, Tang-Long
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2016, 16
  • [25] Ophiocordyceps formosana improves hyperglycemia and depression-like behavior in an STZ-induced diabetic mouse model
    Chao-Wei Huang
    Tzu-Wen Hong
    Ying-Jing Wang
    Ko-Chien Chen
    Ju-Chun Pei
    Tai-Yuan Chuang
    Wen-Sung Lai
    Sheng-Hong Tsai
    Richard Chu
    Wei-Cheng Chen
    Lee-Yan Sheen
    Satoru Takahashi
    Shih-Torng Ding
    Tang-Long Shen
    BMC Complementary and Alternative Medicine, 16
  • [26] Investigating The Role of The Parabrachial Nucleus to Central Amygdala Pathway in The Transition from Acute to Chronic Pain in a Mouse Model of Neuropathic Pain
    Wilson, Torri D.
    Singh, Sudhuman
    Torres-Rodriguez, Jeitzel M.
    Carrasquillo, Yarimar
    JOURNAL OF PAIN, 2024, 25 (04): : 4 - 5
  • [27] Behavioral and Neurobiological Effects of Deep Brain Stimulation in a Mouse Model of High Anxiety- and Depression-Like Behavior
    Schmuckermair, Claudia
    Gaburro, Stefano
    Sah, Anupam
    Landgraf, Rainer
    Sartori, Simone B.
    Singewald, Nicolas
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 (07) : 1234 - 1244
  • [28] Behavioral and Neurobiological Effects of Deep Brain Stimulation in a Mouse Model of High Anxiety- and Depression-Like Behavior
    Claudia Schmuckermair
    Stefano Gaburro
    Anupam Sah
    Rainer Landgraf
    Simone B Sartori
    Nicolas Singewald
    Neuropsychopharmacology, 2013, 38 : 1234 - 1244
  • [29] (2R,6R)-hydroxynorketamine rescues chronic stress-induced depression-like behavior through its actions in the midbrain periaqueductal gray
    Chou, Dylan
    Peng, Hsien-Yu
    Lin, Tzer-Bin
    Lai, Cheng-Yuan
    Hsieh, Ming-Chun
    Wen, Yang-Cheng
    Lee, An-Sheng
    Wang, Hsueh-Hsiao
    Yang, Po-Sheng
    Chen, Gin-Den
    Ho, Yu-Cheng
    NEUROPHARMACOLOGY, 2018, 139 : 1 - 12
  • [30] Preventive and therapeutic effect of vitamin D on depression-like behavior in a mouse adolescent depression model and its association with BDNF protein expression
    Yang, Xueping
    Miao, Junxiao
    Huang, Yinglin
    Li, Lili
    Zhuang, Gengsen
    FRONTIERS IN PSYCHIATRY, 2024, 15